Ornithine oxoglutarate: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Drugbox | verifiedrevid = 428854330 <!--Combo data--> | type = combo | component1 = Ornithine | class1 = amino acid | component2 = Alpha-ketoglutaric acid | class2 =...")
 
No edit summary
Line 32: Line 32:
<!--Chemical data-->
<!--Chemical data-->
}}
}}
                    __NOTOC__
{{SI}}
{{CMG}}


==Overview==
'''Ornithine oxoglutarate''' (OGO) or '''ornithine α-ketoglutarate''' (OKG) is a drug used in liver therapy.  It is the [[salt (chemistry)|salt]] formed from [[ornithine]] and [[alpha-ketoglutaric acid]].  It is also used to improve nutritional health in elderly patients.<ref>{{cite journal | doi = 10.1016/S0899-9007(02)00849-3 | title = Use of ornithine α-ketoglutarate in clinical nutrition of elderly patients | year = 2003 | author = Blonde-Cynober, F | journal = Nutrition | volume = 19 | pages = 73–5 | pmid = 12507647 | last2 = Aussel | first2 = C | last3 = Cynober | first3 = L | issue = 1}}</ref><ref>{{cite journal | title = A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects | journal = Age and Ageing |date=July 1994 | author = Patrice Brocker, Bruno Vellas, Jean-Louis Albarede, Thierry Poynard | url = http://findarticles.com/p/articles/mi_m2459/is_n4_v23/ai_15657854}}</ref>
'''Ornithine oxoglutarate''' (OGO) or '''ornithine α-ketoglutarate''' (OKG) is a drug used in liver therapy.  It is the [[salt (chemistry)|salt]] formed from [[ornithine]] and [[alpha-ketoglutaric acid]].  It is also used to improve nutritional health in elderly patients.<ref>{{cite journal | doi = 10.1016/S0899-9007(02)00849-3 | title = Use of ornithine α-ketoglutarate in clinical nutrition of elderly patients | year = 2003 | author = Blonde-Cynober, F | journal = Nutrition | volume = 19 | pages = 73–5 | pmid = 12507647 | last2 = Aussel | first2 = C | last3 = Cynober | first3 = L | issue = 1}}</ref><ref>{{cite journal | title = A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects | journal = Age and Ageing |date=July 1994 | author = Patrice Brocker, Bruno Vellas, Jean-Louis Albarede, Thierry Poynard | url = http://findarticles.com/p/articles/mi_m2459/is_n4_v23/ai_15657854}}</ref>


==References==
==References==
{{reflist}}
{{reflist|2}}




{{Bile and liver therapy}}


[[Category:Amino acids]]
[[Category:Amino acids]]
[[Category:Combination drugs]]
[[Category:Drug]]
 
 
{{gastrointestinal-drug-stub}}

Revision as of 19:40, 15 April 2015

Ornithine oxoglutarate
Combination of
Ornithineamino acid
[[{{{component3}}}]]? Class
[[{{{component4}}}]]? Class
[[{{{component5}}}]]? Class
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
  (verify)

WikiDoc Resources for Ornithine oxoglutarate

Articles

Most recent articles on Ornithine oxoglutarate

Most cited articles on Ornithine oxoglutarate

Review articles on Ornithine oxoglutarate

Articles on Ornithine oxoglutarate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ornithine oxoglutarate

Images of Ornithine oxoglutarate

Photos of Ornithine oxoglutarate

Podcasts & MP3s on Ornithine oxoglutarate

Videos on Ornithine oxoglutarate

Evidence Based Medicine

Cochrane Collaboration on Ornithine oxoglutarate

Bandolier on Ornithine oxoglutarate

TRIP on Ornithine oxoglutarate

Clinical Trials

Ongoing Trials on Ornithine oxoglutarate at Clinical Trials.gov

Trial results on Ornithine oxoglutarate

Clinical Trials on Ornithine oxoglutarate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ornithine oxoglutarate

NICE Guidance on Ornithine oxoglutarate

NHS PRODIGY Guidance

FDA on Ornithine oxoglutarate

CDC on Ornithine oxoglutarate

Books

Books on Ornithine oxoglutarate

News

Ornithine oxoglutarate in the news

Be alerted to news on Ornithine oxoglutarate

News trends on Ornithine oxoglutarate

Commentary

Blogs on Ornithine oxoglutarate

Definitions

Definitions of Ornithine oxoglutarate

Patient Resources / Community

Patient resources on Ornithine oxoglutarate

Discussion groups on Ornithine oxoglutarate

Patient Handouts on Ornithine oxoglutarate

Directions to Hospitals Treating Ornithine oxoglutarate

Risk calculators and risk factors for Ornithine oxoglutarate

Healthcare Provider Resources

Symptoms of Ornithine oxoglutarate

Causes & Risk Factors for Ornithine oxoglutarate

Diagnostic studies for Ornithine oxoglutarate

Treatment of Ornithine oxoglutarate

Continuing Medical Education (CME)

CME Programs on Ornithine oxoglutarate

International

Ornithine oxoglutarate en Espanol

Ornithine oxoglutarate en Francais

Business

Ornithine oxoglutarate in the Marketplace

Patents on Ornithine oxoglutarate

Experimental / Informatics

List of terms related to Ornithine oxoglutarate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ornithine oxoglutarate (OGO) or ornithine α-ketoglutarate (OKG) is a drug used in liver therapy. It is the salt formed from ornithine and alpha-ketoglutaric acid. It is also used to improve nutritional health in elderly patients.[1][2]

References

  1. Blonde-Cynober, F; Aussel, C; Cynober, L (2003). "Use of ornithine α-ketoglutarate in clinical nutrition of elderly patients". Nutrition. 19 (1): 73–5. doi:10.1016/S0899-9007(02)00849-3. PMID 12507647.
  2. Patrice Brocker, Bruno Vellas, Jean-Louis Albarede, Thierry Poynard (July 1994). "A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects". Age and Ageing.